CVS
CVS HEALTH Corp
Retail-Drug Stores and Proprietary StoresNYSELarge accelerated filer
Total Trades
37
Buys
7
Sells
17
Largest Trade
$1M+
Insiders
14
Activist Filings
8
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Nelson Steven H | EVP and President | BUY | $1K–$15K | 24 | $53.70 | Jan 27, 2026 |
| Finucane Anne A. | Director | SELL | $500K+ | 8K | $71.02 | Aug 29, 2025 |
| SANSONE GUY P | Director | BUY | $100K–$500K | 2K | $63.70 | Jun 9, 2025 |
| ROBBINS LARRY | Director | SELL | $1M+ | 3.8M | $67.65 | May 6, 2025 |
| LUDWIG EDWARD J | Director | BUY | $50K–$100K | 1K | $53.88 | May 2, 2024 |
| Mahoney Michael F | Director | BUY | $500K+ | 9K | $54.49 | May 2, 2024 |
| Shah Prem S | EVP and Pres-Pharm | SELL | $1M+ | 29K | $76.95 | Feb 16, 2024 |
| LUDWIG EDWARD J | Director | BUY | $100K–$500K | 2K | $70.47 | Nov 6, 2023 |
| Clark James David | SVP | SELL | $1M+ | 26K | $74.92 | Aug 4, 2023 |
| Lynch Karen S | President and CEO | BUY | $500K+ | 14K | $69.75 | May 5, 2023 |
| Moriarty Thomas M | EVP & General Coun… | EXERCISE | $1M+ | 137K | $73.85 | Dec 16, 2022 |
| Moriarty Thomas M | EVP & General Coun… | SELL | $1M+ | 137K | $98.36 | Dec 16, 2022 |
| Lotvin Alan | EVP&President-Phar… | SELL | $1M+ | 143K | $98.94 | Aug 5, 2022 |
| Lotvin Alan | EVP&President-Phar… | EXERCISE | $1M+ | 143K | $57.49 | Aug 5, 2022 |
| Finke Daniel P | EVP/Pres | EXERCISE | $100K–$500K | 10K | $52.37 | Aug 5, 2022 |
| Finke Daniel P | EVP/Pres | SELL | $500K+ | 10K | $100.00 | Aug 5, 2022 |
| Moriarty Thomas M | EVP & General Coun… | EXERCISE | $1M+ | 139K | $61.31 | Jun 30, 2022 |
| Moriarty Thomas M | EVP & General Coun… | SELL | $1M+ | 139K | $95.00 | Jun 30, 2022 |
| Shah Prem S | EVP and Co-Preside… | EXERCISE | $500K+ | 14K | $62.37 | Apr 12, 2022 |
| Shah Prem S | EVP and Co-Preside… | SELL | $1M+ | 17K | $105.00 | Apr 12, 2022 |
| Finke Daniel P | EVP/Pres | SELL | $1M+ | 61K | $100.12 | Apr 6, 2022 |
| Finke Daniel P | EVP/Pres | EXERCISE | $1M+ | 43K | $56.79 | Apr 6, 2022 |
| Shah Prem S | EVP and Co-Preside… | EXERCISE | $500K+ | 5K | $102.26 | Mar 31, 2022 |
| Shah Prem S | EVP and Co-Preside… | SELL | $500K+ | 5K | $104.70 | Mar 31, 2022 |
| Shah Prem S | EVP and Co-Preside… | SELL | $100K–$500K | 5K | $106.65 | Mar 18, 2022 |
| Shah Prem S | EVP and Co-Preside… | EXERCISE | $100K–$500K | 3K | $104.82 | Mar 18, 2022 |
| Moriarty Thomas M | EVP & General Coun… | SELL | $1M+ | 51K | $105.00 | Mar 17, 2022 |
| Moriarty Thomas M | EVP & General Coun… | EXERCISE | $1M+ | 51K | $102.26 | Mar 17, 2022 |
| LUDWIG EDWARD J | Director | BUY | $100K–$500K | 1K | $105.90 | Feb 11, 2022 |
| Brennan Troyen A | EVP and Chief Medi… | EXERCISE | $1M+ | 48K | $102.26 | Feb 4, 2022 |
| Brennan Troyen A | EVP and Chief Medi… | SELL | $1M+ | 48K | $110.00 | Feb 4, 2022 |
| Lotvin Alan | EVP&President-Phar… | EXERCISE | $1M+ | 21K | $102.26 | Feb 2, 2022 |
| Lotvin Alan | EVP&President-Phar… | SELL | $1M+ | 21K | $106.50 | Feb 2, 2022 |
| Clark James David | SVP | SELL | $500K+ | 6K | $109.00 | Feb 1, 2022 |
| Clark James David | SVP | EXERCISE | $500K+ | 6K | $102.26 | Feb 1, 2022 |
| Roberts Jonathan C | COO | EXERCISE | $1M+ | 68K | $102.26 | Jan 28, 2022 |
| Roberts Jonathan C | COO | SELL | $1M+ | 68K | $107.50 | Jan 28, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Jul 16, 2025
8.3%
105.3M shares
SC 13G · May 13, 2025
5.5%
68.8M shares
SC 13G/A · Apr 17, 2025
7.1%
89.2M shares
SC 13G · Nov 13, 2024
5.0%
6.3B shares
SC 13G/A · Oct 24, 2024
8.3%
104.6M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.1%
117.7M shares
SC 13G/A · Jan 26, 2024
6.8%
87.0M shares
SC 13G/A · Jan 31, 2022
7.1%
93.6M shares